AKDEMİR, B. Et Al. 2024. Genome-wide CRISPR Screening Identifies RUVBL1/2 Complex as a Druggable Vulnerability in Bladder Cancer. The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) , (Rotterdam, Netherlands), 180-181.

AKDEMİR, B., ERİŞ, S., Kalyoncu, M., ÇAKIROĞLU, E., Coşkun, Ö. Ş., KARAKÜLAH, G., ... ŞENTÜRK, Ş.(2024). Genome-wide CRISPR Screening Identifies RUVBL1/2 Complex as a Druggable Vulnerability in Bladder Cancer . The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) (pp.180-181). Rotterdam, Netherlands

AKDEMİR, BUSE Et Al. "Genome-wide CRISPR Screening Identifies RUVBL1/2 Complex as a Druggable Vulnerability in Bladder Cancer," The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024), Rotterdam, Netherlands, 2024

AKDEMİR, BUSE Et Al. "Genome-wide CRISPR Screening Identifies RUVBL1/2 Complex as a Druggable Vulnerability in Bladder Cancer." The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) , Rotterdam, Netherlands, pp.180-181, 2024

AKDEMİR, B. Et Al. (2024) . "Genome-wide CRISPR Screening Identifies RUVBL1/2 Complex as a Druggable Vulnerability in Bladder Cancer." The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) , Rotterdam, Netherlands, pp.180-181.

@conferencepaper{conferencepaper, author={BUSE AKDEMİR Et Al. }, title={Genome-wide CRISPR Screening Identifies RUVBL1/2 Complex as a Druggable Vulnerability in Bladder Cancer}, congress name={The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024)}, city={Rotterdam}, country={Netherlands}, year={2024}, pages={180-181} }